NERV FEB 8 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Minerva Neurosciences, Inc. – NERV

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Minerva Neurosciences, Inc. (NASDAQ: NERV) from May 15, 2017 through November 30, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Minerva Neurosciences, Inc. investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than February 8, 2021.  

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: the truth about the feedback received from the FDA concerning the “end-of-Phase 2” meeting; the Phase 2b study did not use the commercial formulation of roluperidone and was conducted solely outside of the United States; the failure of the Phase 3 study to meet its primary and key secondary endpoints rendered that study incapable of supporting substantial evidence of effectiveness; the Company’s plan to use the combination of the Phase 2b and Phase 3 studies would be “highly unlikely” to support the submission of an NDA; reliance on these two trials in the submission of an NDA would lead to “substantial review issues” because the trials were inadequate and not well-controlled; and as a result, the Company’s public statements were materially false and misleading at all relevant times.

If you wish to serve as lead plaintiff, you must move the Court no later than February 8, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:
Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1410
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
[email protected]



ACMR FEB 19 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against ACM Research, Inc. – ACMR

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of ACM Research, Inc. (NASDAQ: ACMR) from March 6, 2019 through October 7, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for ACM Research, Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit,  defendants made false and/or misleading statements and/or failed to disclose that: the Company’s revenue and profits had been diverted to undisclosed related parties; accordingly, the Company had materially overstated its revenues and profits; and as a result, defendants’ statements about ACM’s business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than February 19, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:  
Vik Pawar, Esq.  
Pawar Law Group  
20 Vesey Street, Suite 1410  
New York, NY 10007  
Tel: (917) 261-2277  
Fax: (212) 571-0938  
[email protected]  



FEB 9 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Qiwi plc– QIWI

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Qiwi plc (NASDAQ: QIWI) from March 28, 2019 through December 9, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Qiwi plc investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Qiwi’s internal controls related to reporting and record-keeping were ineffective; consequently, the Central Bank of Russia would impose a monetary fine upon the Company and impose restrictions upon the Company’s ability to make payments to foreign merchants and transfer money to pre-paid cards; and as a result, Defendants’ public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than February 9, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:
Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1410
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
[email protected]



Virtual Medical International (OTC: QEBR) Signs Agreement To Open Ten New Whole Health Stores With Natural Life In Florida

PR Newswire

LAS VEGAS, Feb. 3, 2021 /PRNewswire/ — Virtual Medical International Inc. (OTC: QEBR), a whole health Wellness company in the hemp-derived CBD sector, today announced that it has entered into an agreement to collaborate with Natural Life to open 10 new whole health stores in Florida, one of America’s largest consumer markets.

Virtual Medical “QEBR” has entered an agreement to expand Natural Life outlets in Florida in a joint venture revenue sharing agreement. The Natural Life franchise currently has 4 operating stores and is expanding by opening 10 more Stores in Florida in 2021 with QEBR in a joint venture.

Natural Life’s Founder, Gabriel Suarez, stated: “Natural Life is eager to join with Virtual Medical in the joint venture.  This a significant next step forward in adding to our initiative for the franchise expansion business opportunity. It is exciting to have a proven model like Natural Life join with Virtual Medical to offer this new opportunity to prospects that want to get into the whole health space.”

Larson Elmore CEO of QEBR commented in endorsing the joint venture that “Natural Life is a great brand for QEBR to collaborate with as this deal gives us an immediate presence in the Southeast U.S. market, as well as the ability to increase our footprint across the USA as we move forward with our planned expansion strategy.”

This joint venture is expected to duplicate Natural Life’s very successful format to establish a larger chain of retail stores that specialize in whole health products and other holistic products such as Kava, Turmeric, Akuamma, Ginseng and Ashwagandha. Natural Life as a company can offer more than 300 CBD products and over 20 brands through its stores and website.Quality and safety are at the forefront, and QEBR is conscious that it needs to ensure that these brands are compliant with all upcoming 2021 regulations. In addition, Natural Life provides its own third-party lab testing (regardless of the manufacturer’s own test results). Their attention to quality and safety has led to the successful vetting and approval by Publix supermarkets to be co-located in these big box stores. This store model verifies that a similar model can co-locate in other big chain retailers SEE: https://www.shopnaturallife.com

Mr. Elmore added that “this structure will enable the Company to control the quality and breadth of its product offerings, as well as manage, build and support a national distribution network.” 

The potential for growth in the sector is demonstrated by almost all of the sector’s public companies enjoying an increase in share prices. Marijuana stocks continued to rally on Wednesday after Jazz Pharmaceuticals (JAZZ) announced it would acquire GW Pharmaceuticals (GWPH), a drugmaker best known for a cannabis-derived medication for epileptic seizures.  The $7.2 billion deal was announced after Senate Majority Leader Charles Schumer and Sens. Cory Booker and Ron Wyden this week said they would make cannabis reform a priority this year.

Larson noted that “this legislation would legalize cannabis at the Federal Level.  Many observers believe the Biden administration will support passing this legislation.  In that case, the company is well positioned to take advantage of the opportunity.  We would anticipate that if this legislation is passed, it will be a major step forward for the cannabis industry — already one of the fastest growing industries in the USA.”

About Virtual Medical International

Virtual Medical International, (OTC: QEBR), through its wholly-owned subsidiary, has trademarked the brand name “Amsterdam Café: Welcome to Your Whole Health”™. The diversified, multi-channel business model is positioned to derive revenue from product sales through company-owned retail stores, franchise stores, domestic and international franchise activities, third party contract manufacturing, e-commerce and corporate alignments.

Virtual Medical International’s business model is designed to help consumers improve the health and quality of their lives by making available an array of high quality, CBD-centric products consistent with a healthy lifestyle. To that end, Virtual Medical formed Amsterdam Café as a wholly owned subsidiary in order to become a comprehensive, vertically integrated organization within the CBD whole health sector,with plans to acquire and open CDB Stores across the U.S.A. and Europe.

See: www.buyamsterdamcafe.com

For further information:

Contact:

Larson Elmore

Phone: (216) 345-4567
Email: [email protected]

Forward-Looking Statements

Legal Notice Regarding Forward-Looking Statements in this news release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined, and assumptions of management. Forward looking statements are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “aims”, “potential”, “goal”, “objective”, “prospective”, and similar expressions or that events or conditions “will”, “would”, “may”, “can”, “could” or “should” occur.

Actual results may differ materially from those currently anticipated due to a number of factors beyond the reasonable control of the Company. It is important to note that actual outcomes and the Company’s actual results could differ materially from those in such forward-looking statements. Factors that could cause actual results to differ materially include misinterpretation of data, the Company’s ability to raise financing for operations, breach by parties with whom we have contracted, and the possible inability to maintain qualified employees or consultants.

For more information please see our website: http://www.qebr.net

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/virtual-medical-international-otc-qebr-signs-agreement-to-open-ten-new-whole-health-stores-with-natural-life-in-florida-301221608.html

SOURCE QEBR

Canada’s unions welcome new terrorist listings for far-right white supremacist groups

Le français suit

OTTAWA, Feb. 03, 2021 (GLOBE NEWSWIRE) — Canada’s unions welcome today’s announcement by the federal government that it has added four violent, far-right extremist groups to its list of terrorist organizations.

The Proud Boys, the Base, Atomwaffen, and the Russian Imperial Movement have been listed as terrorist entities. This means that these groups can no longer raise money or organize.

“These groups are a direct threat to the safety and wellbeing of workers of all backgrounds and specifically to those who are Indigenous, Black, Jewish, Muslim, or who represent other minority communities,” said Hassan Yussuff, President of the Canadian Labour Congress (CLC). “We have seen a drastic resurgence in far-right extremist behaviour over the past several years. Letting these groups operate unchecked is dangerous and poses a real threat to our democracy and to the wellbeing of our communities. Today’s announcement is a welcome step in addressing this scourge.”

Unions in Canada have a long history of organizing against racism through advocacy and education. But far-right groups have thrived online, and the use of social media in particular has made it difficult to stem their use of misinformation to recruit new members and to mobilize.

Last year and for the first time ever, the federal government added two white-supremacist groups to the list of terrorist organizations.

“The reality is that white supremacist groups have not faced the same scrutiny as other racialized groups and that has allowed them to mobilize with relative freedom and impunity,” added Yussuff. “Furthermore, under anti-terror legislation, stereotypes and guilt by association have led to the over-surveillance of Muslim and Arab communities. Public safety measures must not stigmatize specific communities.”

According to counter-terrorism experts in Canada, there were 100 alt-right or white supremacist groups operating in Canada in 2015. There is widespread concern that those numbers are growing.

“Attacks by white supremacists tend to be targeted, and do not happen in isolation. The climate of hatred they foster puts workers’ health and safety at risk,” said Larry Rousseau, Executive Vice-President at the CLC. “Incidents of intimidation at work and online harassment are on the rise, and must stop. Everyone deserves to live free from violence and harassment.”

To arrange an interview, please contact:

CLC Media Relations
[email protected]
613-526-7426



QSR FEB 19 DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Restaurant Brands International Inc.– QSR

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Restaurant Brands International Inc. (NYSE: QSR) from April 29, 2019 through October 28, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Restaurant Brands International Inc. investors under the federal securities laws. If you wish to serve as lead plaintiff, you must move the Court no later than February 19, 2021.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Restaurant Brands’ “Winning Together Plan” was failing to generate substantial, sustainable improvement within the Tim Hortons brand; the “Tims Rewards” loyalty program was not generating sustainable revenue growth as increased customer traffic was not offsetting promotional discounting; and as a result, defendants’ statements about Restaurant Brands’ business, operations, and prospects lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than February 19, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1410
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
[email protected]



Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24

Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24

CINCINNATI–(BUSINESS WIRE)–
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2020, on Tuesday, February 23, 2021, following the close of trading on the New York Stock Exchange.

Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, February 24, 2021, to discuss the company’s quarterly results and to provide an update on its business.

The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants. The participant Conference ID is 7865216. A live webcast of the call can be accessed on Chemed’s website at www.chemed.com by clicking on Investor Relations Home.

A taped replay of the conference call will be available beginning approximately two hours after the call’s conclusion. It can be accessed by dialing toll-free 855-859-2056 for U.S. and Canadian callers and +1 404-537-3406 for international callers and will be available for one week following the live call. The replay Conference ID is 7865216. An archived webcast will also be available at www.chemed.com.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed’s future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

David P. Williams

(513) 762-6901

KEYWORDS: United States North America Ohio

INDUSTRY KEYWORDS: Environment Commercial Building & Real Estate Construction & Property Other Retail Managed Care General Health Health Other Construction & Property Retail Residential Building & Real Estate

MEDIA:

Logo
Logo

AZN DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against AstraZeneca PLC– AZN

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of AstraZeneca PLC (NASDAQ: AZN) from May 21, 2020 through November 20, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for AstraZeneca PLC investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit,  defendants made false and/or misleading statements and/or failed to disclose that: initial clinical trials for AZD1222, the Company’s coronavirus vaccine hopeful, had suffered from a critical manufacturing error, resulting in a substantial number of trial participants receiving half the designed dosage; clinical trials for AZD1222 consisted of a patchwork of disparate patient subgroups, each with subtly different treatments, undermining the validity and import of the conclusions that could be drawn from the clinical data across these disparate patient populations; certain clinical trial participants for AZD1222 had not received a second dose at the designated time points, but rather received the second dose up to several weeks after the dose had been scheduled to be delivered according to the original trial design; AstraZeneca had failed to include a substantial number of patients over 55 years of age in its clinical trials for AZD1222, despite this patient population being particularly vulnerable to the effects of COVID-19 and thus a high priority target market for the drug; AstraZeneca’s clinical trials for AZD1222 had been hamstrung by widespread flaws in design, errors in execution, and a failure to properly coordinate and communicate with regulatory authorities and the general public; as a result of the foregoing, the clinical trials for AZD1222 had not been conducted in accordance with industry best practices and acceptable standards and the data and conclusions that could be derived from the clinical trials was of limited utility; and as a result of the foregoing, AZD1222 was unlikely to be approved for commercial use in the United States in the short term, one of the largest potential markets for the drug.

If you wish to serve as lead plaintiff, you must move the Court no later than March 29, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:  
Vik Pawar, Esq.  
Pawar Law Group  
20 Vesey Street, Suite 1410  
New York, NY 10007  
Tel: (917) 261-2277  
Fax: (212) 571-0938  
[email protected]  



SWI DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against SolarWinds Corporation – SWI

NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pawar Law Group announces a class action lawsuit on behalf of shareholders who purchased shares of SolarWinds Corporation (NYSE: SWI) from February 24, 2020 through December 15, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for SolarWinds Corporation investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email [email protected] for information on the class action.

According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; SolarWinds’ update server had an easily accessible password of ‘solarwinds123’; consequently, SolarWinds’ customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; as a result, the Company would suffer significant reputational harm; and as a result, Defendants’ statements about SolarWinds’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

If you wish to serve as lead plaintiff, you must move the Court no later than March 5, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

No class has been certified. Until a class is certified, you are not represented by counsel unless you hire one. You may hire counsel of your choice. You may also do nothing at this time and be an absent member of the class. Your ability to share in any future recovery is not dependent upon being a lead plaintiff.

Pawar Law Group represents investors from around the world. Attorney advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
——————————-

Contact:
Vik Pawar, Esq.
Pawar Law Group
20 Vesey Street, Suite 1410
New York, NY 10007
Tel: (917) 261-2277
Fax: (212) 571-0938
[email protected]



Brookdale Senior Living Investors Who Have Held Their Stock Continuously Since At Least 2019 Encouraged To Contact Kehoe Law Firm, P.C.

PHILADELPHIA, Feb. 03, 2021 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating whether certain officers and/or directors of Brookdale Senior Living Inc. (“Brookdale” or the “Company”) (NYSE: BKD) breached their fiduciary duties to Brookdale and the Company’s shareholders.

The investigation concerns whether certain officers and/or directors of Brookdale, among other things, failed to disclose and/or made misleading statements regarding Brookdale’s business, operational, and legal profiles, including whether the Company intentionally underestimated data inputs to meet financial benchmarks.


If you have held Brookdale stock continuously since at least 2019

and wish to discuss Kehoe Law Firm’s investigation or have questions about your potential legal rights, please contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804,

[email protected]

,

[email protected]

,

[email protected]

, to learn more about the

investigation or potential legal claims

.

Kehoe Law Firm, P.C., with offices in New York and Philadelphia, is a multidisciplinary, plaintiff–side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct.  Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion dollars on behalf of institutional and individual investors.   

This notice may constitute attorney advertising.